Children with atopic dermatitis have higher ADHD risk, particularly with early, severe disease and sleep disturbance, a review found.
|Articles|February 27, 2008
Humira approved for juvenile rheumatoid arthritis
Abbott's Humira (adalimumab) had been approved by the food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis...
Advertisement
Abbott's Humira (adalimumab) has been approved by the Food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis.
JVA joins other indications including chronic plaque psoriasis, rheumatoid arthritis in adults, and Crohn's disease.
Advertisement
Related to this article
Baseline severity and clinical phenotype may help predict response to systemic therapy in children with alopecia areata.
Can you guess the diagnosis?
Can you guess the diagnosis?
Phase 3 data show lebrikizumab improved skin clearance, itch, and quality of life in children with moderate-to-severe atopic dermatitis.
Lisa Swanson, MD, describes AD as fundamentally unpredictable — a roller coaster of flares and quiet stretches that can wear down patients and families alike.
Lisa Swanson, MD, returns to diagnostic pitfalls, describing a presentation she sees often: AD in the crease of an infant's neck, which is frequently misdiagnosed as a yeast infection.
A Rutgers-led study finds teens who follow beauty influencers or watch tutorials use significantly more personal care products, many containing endocrine-disrupting chemicals.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Updated AAP guidance changes iron deficiency screening and treatment in children
2
FDA grants priority review to efzimfotase alfa for hypophosphatasia in patients aged 2 years and older
3
FDA approves levacetylleucine as first treatment for ataxia in ataxia-telangiectasia
4
Fenfluramine shows sustained seizure reduction, functional improvement in Lennox-Gastaut syndrome
5